Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Molecular Oncology|October 11, 2021
Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphomaGiulio Donati, Micol Ravà, Marco Filipuzzi, et al.
Scientific Reports|February 14, 2019
Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor modelsZebin Wang, Kaiming Sun, Yonghong Xiao, et al.
Frontiers in Oncology|July 23, 2020
Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse ModelMateusz Rytelewski, Karine Harutyunyan, Natalia Baran, et al.
Leukemia|November 4, 2017
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapyV K Patel, B Lamothe, M L Ayres, et al.
Blood|June 3, 2015
Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapyByung-Sik Cho, Zhihong Zeng, Hong Mu, et al.
Blood Advances|August 23, 2021
Development and characterization of prototypes for in vitro and in vivo mouse models of ibrutinib-resistant CLLBurcu Aslan, Gorkem Kismali, Lisa S Chen, et al.
Molecular Cancer Research : MCR|September 16, 2022
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate CancerFederica Mossa, Daniele Robesti, Ramachandran Sumankalai, et al.
Molecular Cell|May 17, 2024
Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancersChao Mao, Guang Lei, Amber Horbath, et al.
Cell Cycle (Georgetown, Tex.)|August 5, 2009
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNTZhan Zhang, Hong Sun, Hongyue Dai, et al.
JCI Insight|April 20, 2018
Generation and testing of clinical-grade exosomes for pancreatic cancerMayela Mendt, Sushrut Kamerkar, Hikaru Sugimoto, et al.
Pageof 7